Second Treatment Course May Increase Mesothelioma Patient Survival
Oncologists report that a second treatment course may be a good option for some mesothelioma patients. Almost all mesothelioma patients…
Predicting How a Patient Will Respond to Mesothelioma Treatment
Malignant pleural mesothelioma is a rare cancer. Early diagnosis is challenging. Treatments are the first clinical option in the advanced…
First-Line Chemotherapy versus Immunotherapy versus Maintenance Therapy
A recent study compared mesothelioma patients’ survival by physician’s choice of treatment. Is first-line chemotherapy the best choice? Malignant pleural…
Nivolumab + Ipilimumab Provides Long-Term Survival Benefit in Malignant Pleural Mesothelioma
Nivolumab + ipilimumab continues to provide a long-term survival benefit in malignant pleural mesothelioma. A new report shows a 3-year…
New Artificial Intelligence Tool Measures Mesothelioma Tumors
A new artificial intelligence tool can measure mesothelioma tumors without any human input. Automated mesothelioma tumor measurement is now possible.…
Bevacizumab: An Immune Therapy in Mesothelioma Treatment
Bevacizumab, an immune therapy, enhances the immune system to target cancer cells. Historically, chemotherapy drugs were considered the standard treatment.…
Chemotherapy | Europe | International | Research | Treatments | Virus
Goat Virus Proves Lethal to Mesothelioma Cells in Italian Study
Researchers in Italy say a virus normally found in goats could offer a new, safer way to kill malignant mesothelioma…
Asia | Chemotherapy | International | Surgery | Treatments
Korean Cancer Doctors Embrace PIPAC for Mesothelioma
Five out of ten Korean oncologists surveyed feel positive about using an aerosolized chemotherapy system called PIPAC for mesothelioma and…
Chemotherapy Still Good First-Line Option for Unresectable Epithelioid Mesothelioma
A top mesothelioma expert says chemotherapy may still be the best first-line treatment for unresectable epithelioid mesothelioma, even though immunotherapy…
Mesothelioma Histology Impacts Response to Chemotherapy
Response to chemotherapy for people with malignant mesothelioma may depend – at least in part – on the histology or…